Company intelligence / Profile preview

Resolution

Edinburgh, Scotland, United Kingdomresolution-tx.com ↗
Ownership
Private
Employees
~51
Development stage
Other
01

Overview

Resolution Therapeutics is pioneering macrophage cell therapy for patients at risk of hepatic decompensation in chronic liver disease, aiming to provide an alternative to liver transplantation; clinical results are not yet publicly available, as programs are preclinical[1][2][4].

Therapeutic areas
ImmunologyGastroenterology
Modalities
Cell therapyMacrophage cell therapy
Industry
Biotech
02

Partnerships

Syncona Investment Management Limited

Beyond the preview

Go deeper on Resolution.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Resolution.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call